Peter L Perrotta
Overview
Explore the profile of Peter L Perrotta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
341
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perrotta P, Coulter S, Blond B, Long T, Schifman R
Arch Pathol Lab Med
. 2024 Nov;
PMID: 39603254
Context.—: Test-ordering practices vary widely between and within health care organizations, and methods used to benchmark test utilization data are unstandardized. Objective.—: To develop and apply standardized methodology to compare...
2.
Wang J, Yu T, Kolodney M, Perrotta P, Hu G
Ann Biomed Eng
. 2024 Nov;
53(1):5-8.
PMID: 39602035
Color vision deficiency (CVD) affects a significant portion of the population, yet its impact is often overlooked in medical education, especially in visually demanding specialties like dermatology, pathology, and radiology....
3.
Lindholm P, Saluja R, Long T, Coulter S, Blond B, Perrotta P
Arch Pathol Lab Med
. 2024 Nov;
PMID: 39561786
Context.—: Opportunities to improve transfusion safety occur at lower hemoglobin (Hgb) thresholds and single-unit transfusions. Efforts to improve compliance with transfusion guidelines and single-unit transfusion practices reduce transfusions and lead...
4.
Sasi R, Spruill M, Perrotta P
Case Rep Hematol
. 2024 Mar;
2024:2127657.
PMID: 38550770
Evidence suggests that the earliest genetic events in the evolution of a cancer can predate diagnosis by several years or decades. In chronic myeloid leukemia (CML), the BCR::ABL1 fusion driver...
5.
Sasi R, Senft J, Spruill M, Barua S, Dougaparsad S, Vos J, et al.
Mol Cytogenet
. 2022 Dec;
15(1):51.
PMID: 36474285
Background: A patient with a myelodysplastic neoplasm exhibited a karyotype with multiple complex chromosome 5 rearrangements. This patient appeared to have a catastrophic cytogenetic event that manifested as a treatment-refractory...
6.
Smoot K, Yang J, Tacker D, Welch S, Khodaverdi M, Kimble W, et al.
JAMA Netw Open
. 2022 Sep;
5(9):e2231334.
PMID: 36098966
Importance: West Virginia prioritized SARS-CoV-2 vaccine delivery to nursing home facilities because of increased risk of severe illness in elderly populations. However, the persistence and protective role of antibody levels...
7.
Peppers B, Shmookler A, Stanley J, Giblin Sutton L, Perrotta P, Kieffer T, et al.
Allergy Rhinol (Providence)
. 2022 Jul;
13:21526575221110488.
PMID: 35795339
Purpose: The rapid spread of SARS-CoV-2, the virus that is responsible for causing COVID-19, has presented the medical community with another example of when convalescent plasma (CP) is still used...
8.
Shmookler A, Nichols T, Perrotta P
Am J Clin Pathol
. 2021 Feb;
156(2):246-252.
PMID: 33609094
Objectives: The role of transfusion medicine consultative services in prospectively auditing (PA) orders for four-factor prothrombin complex concentrate (4F-PCC) was evaluated at an academic medical center. Methods: Data from 4...
9.
Horspool A, Kieffer T, Russ B, DeJong M, Wolf M, Karakiozis J, et al.
mSphere
. 2021 Jan;
6(1).
PMID: 33472985
The SARS-CoV-2 pandemic is impacting the global population. This study was designed to assess the interplay of antibodies with the cytokine response in SARS-CoV-2 patients. We demonstrate that significant levels...
10.
Tacker D, Perrotta P
J Appl Lab Med
. 2020 Dec;
1(6):678-689.
PMID: 33379827
Background: An antinuclear antibody (ANA) testing strategy involving enzyme immunoassay (EIA) screening that reflexed to immunofluorescence assay (IFA) was implemented, monitored, and optimized for clinical utility. Methods: The clinical utility,...